| Literature DB >> 26597584 |
Jérémie Jacques1, Paul Carrier2, Marilyne Debette-Gratien1, Rodolphe Sobesky3, Véronique Loustaud-Ratti4.
Abstract
Hepatic encephalopathy is a severe complication of liver cirrhosis and is an important therapeutic challenge, with a social and economic issue. If, now, the pathophysiology is not totally understood (main role of ammonia, but a better understanding of cerebral mechanisms), the clinical presentation is well-known. Some treatments are useful (disaccharides, treatment of the trigger) but their efficiency is limited. Nevertheless, the emergence of new treatments, such as non-absorbable antibiotics (rifaximin essentially), is an interesting therapeutic tool.Entities:
Mesh:
Year: 2015 PMID: 26597584 DOI: 10.1016/j.lpm.2015.02.021
Source DB: PubMed Journal: Presse Med ISSN: 0755-4982 Impact factor: 1.228